Literature DB >> 16005142

Hormones and growth factors regulate telomerase activity in ageing and cancer.

Sharyn Bayne1, Jun-Ping Liu.   

Abstract

Telomerase is a specialised reverse transcriptase that synthesises and preserves telomeres (the ends of chromosomes), thereby playing a key role in regulating the lifespan of cell proliferation. Telomerase activity is critically involved in cell development, ageing and tumourigenesis. Activation of telomerase to maintain telomeres is required for self renewal and proliferative expansion of a number of cell types, including stem cells, activated lymphocytes and cancerous cells. However, recent studies show that the safeguard mechanisms and the modes of regulation of telomerase are more revealing than thought under various physiological and pathological conditions. Considerable evidence suggests that hormones and growth factors are crucially involved in regulating telomerase activity and gene expression of telomerase reverse transcriptase (TERT). This review briefly summarises our current understanding of how hormones and growth factors regulate the telomerase and telomere network and how deregulation can induce ageing and related diseases such as cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005142     DOI: 10.1016/j.mce.2005.05.009

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  31 in total

Review 1.  Review. Meiotic drive and sex determination: molecular and cytological mechanisms of sex ratio adjustment in birds.

Authors:  Joanna Rutkowska; Alexander V Badyaev
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-05-12       Impact factor: 6.237

2.  Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells.

Authors:  Rodrigo T Calado; William T Yewdell; Keisha L Wilkerson; Joshua A Regal; Sachiko Kajigaya; Constantine A Stratakis; Neal S Young
Journal:  Blood       Date:  2009-06-26       Impact factor: 22.113

Review 3.  Short Telomere Syndromes in Clinical Practice: Bridging Bench and Bedside.

Authors:  Abhishek A Mangaonkar; Mrinal M Patnaik
Journal:  Mayo Clin Proc       Date:  2018-05-24       Impact factor: 7.616

Review 4.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

5.  Danazol Treatment for Telomere Diseases.

Authors:  Danielle M Townsley; Bogdan Dumitriu; Delong Liu; Angélique Biancotto; Barbara Weinstein; Christina Chen; Nathan Hardy; Andrew D Mihalek; Shilpa Lingala; Yun Ju Kim; Jianhua Yao; Elizabeth Jones; Bernadette R Gochuico; Theo Heller; Colin O Wu; Rodrigo T Calado; Phillip Scheinberg; Neal S Young
Journal:  N Engl J Med       Date:  2016-05-19       Impact factor: 91.245

6.  Roles of CDX2 and EOMES in human induced trophoblast progenitor cells.

Authors:  Ying Chen; Kai Wang; Yun Guo Gong; Sok Kean Khoo; Richard Leach
Journal:  Biochem Biophys Res Commun       Date:  2013-01-08       Impact factor: 3.575

7.  Effect of EGF and FGF on the expansion properties of human umbilical cord mesenchymal cells.

Authors:  Parvin Salehinejad; Noorjahan Banu Alitheen; Ali Mandegary; Seyed Noureddin Nematollahi-Mahani; Ehsan Janzamin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-25       Impact factor: 2.416

Review 8.  Telomere maintenance and human bone marrow failure.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

9.  Immortalization of epithelial progenitor cells mediated by resveratrol.

Authors:  V P Pearce; J Sherrell; Z Lou; L Kopelovich; W E Wright; J W Shay
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

Review 10.  Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event?

Authors:  S Ray; H I Swanson
Journal:  Biochem Pharmacol       Date:  2008-11-27       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.